Journal profile · GASTROENTEROLOGY & HEPATOLOGY-SURGERY
HPB
ISSN 1365-182X · eISSN 1477-2574 · John Wiley and Sons Inc. · ENGLAND
HPB: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.94; hybrid open access; APC about USD 4,100; median 88 days to acceptance (103 articles, last 24 months); community-reported acceptance: fairly easy; 1,501 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
HPB is published by John Wiley and Sons Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pancreatic and Hepatic Oncology Research, Hepatocellular Carcinoma Treatment and Prognosis and Cholangiocarcinoma and Gallbladder Cancer Studies, together about 41.6% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
To visit the HPB journal website click here: http://www.hpbonline.org/HPB is an international forum for clinical, scientific and educational communication.Twelve issues a year bring the reader leading articles, expert reviews, original articles, images, editorials, and reader correspondence encompassing all aspects of benign and malignant hepatobiliary disease and its management. HPB features relevant aspects of clinical and translational research and practice.Specific areas of interest include HPB diseases encountered globally by clinical practitioners in this specialist field of gastrointestinal surgery. The journal addresses the challenges faced in the management of cancer involving the liver, biliary system and pancreas. While surgical oncology represents a large part of HPB practice, submission of manuscripts relating to liver and pancreas transplantation, the treatment of benign conditions such as acute and chronic pancreatitis, and those relating to hepatobiliary infection and inflammation are also welcomed. There will be a focus on developing a multidisciplinary approach to diagnosis and treatment with endoscopic and laparoscopic approaches, radiological interventions and surgical techniques being strongly represented. HPB welcomes submission of manuscripts in all these areas and in scientific focused research that has clear clinical relevance to HPB surgical practice.HPB aims to help its readers - surgeons, physicians, radiologists and basic scientists - to develop their knowledge and practice. HPB will be of interest to specialists involved in the management of hepatobiliary and pancreatic disease however will also inform those working in related fields.HPB is owned by the International Hepato-Pancreato-Biliary Association (IHPBA) and is also the official Journal of the American Hepato-Pancreato-Biliary Association (AHPBA), the Asian-Pacific Hepato Pancreatic Biliary Association (A-PHPBA) and the European-African Hepato-Pancreatic Biliary Association (E-AHPBA).
From the journal's Aims & Scope
Research area (LetPub): GASTROENTEROLOGY & HEPATOLOGY-SURGERY
Editor-in-chief S.J. WigmorePublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 28, United Kingdom 9, Japan 8, France 4, Canada 4 (78 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pancreatic and Hepatic Oncology ResearchMedicine19.4%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine12.2%
- Cholangiocarcinoma and Gallbladder Cancer StudiesMedicine10%
- Gallbladder and Bile Duct DisordersMedicine9.8%
- Pancreatitis Pathology and TreatmentMedicine7.8%
- Organ Transplantation Techniques and OutcomesMedicine5.8%
- Liver Disease Diagnosis and TreatmentMedicine4.1%
- Liver Disease and TransplantationMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
| Minor | Surgery | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Surgery | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.94LetPub ·
- Impact factor (publisher)
- 3.3Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- SJR 2026-06
- 1.07LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 62LetPub ·
- h-index
- 118OpenAlex ·
- i10-index
- 2,256OpenAlex ·
- 2-year mean citedness
- 0.33OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 23.24%LetPub ·
Volume
- Articles per year
- 163LetPub ·
Articles by year OpenAlex count · 21,232 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 634 | 42 | 39 |
| 2025 | 1,501 | 1,415 | 343 |
| 2024 | 2,158 | 2,156 | 1,040 |
| 2023 | 1,447 | 1,447 | 1,758 |
| 2022 | 1,502 | 1,502 | 1,863 |
| 2021 | 2,589 | 2,589 | 4,070 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
88 daysMedian, submission to acceptance · P25–P75 35 days – 125 days
- Acceptance to online
- median 5 days (103 articles)
- Submission to online
- median 93 days
- Sample
- 103 articles with submission and acceptance dates (408 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- First decision after review
- 65 daysPublisher website ·
- Submission to acceptance
- 122 daysPublisher website ·
- Acceptance to publication
- 5 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,100 / EUR 3,840 / GBP 3,280 / JPY 508,520 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 200 words
- Manuscript length
- ≤ 5,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Optional
Article types accepted5, with length limits
- case studyPlease note that HPB no longer publishes Case Studies, Technical Reports, Image of the Issue and How I do it. Authors interested in submitting manuscripts in th…Length not stated
- correspondenceThe Editors welcome topical correspondence from readers relating to articles published in the Journal. Letters must be no more than 250 words in length, includi…main text ≤ 250 words
- letteroriginal data are considered. Research Letters must be no more than 1000 words in length, with no more than 10 references, and two figuresmain text ≤ 1,000 words
- original articleOriginal articles should normally be in the format of Introduction, Methods, Results and Discussion. Original articles must include a structured abstract of 200…main text ≤ 200 words · abstract ≤ 200 words · references ≤ 50
- reviewPriority will be given to work that addresses a topic of current interest. All meta-analyses of randomized trials must adhere to the guidelines outlined in the …main text ≤ 200 words · abstract ≤ 200 words · references ≤ 75
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship
For research papers, Authorship should be decided at the launch of the study. The Authorship credit should be based on 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Authors should meet co…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Publication ethics
Follows ICMJE policies and COPE publishing ethics guidelines Model summary
HPB subscribes to the policies published by the International Committee of Medical Journal Editors (ICMJE) and adheres to publishing ethics guidelines published by the Committee on Publication Ethics (COPE).
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·- Trial registration / reporting guidelines
Prospective clinical trials must be registered in a suitable electronic and freely accessible registry according to ICMJE guidelines Model summary
HPB expects all authors to register prospective clinical trials in a suitable electronic and freely accessible registry (e.g. www.clinicaltrials.gov, www.controlled-trials.com), according to the ICMJE guidelines
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Inc.
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 1365-182X
- Electronic ISSN
- 1477-2574
- Society / sponsor
- American Hepato-Pancreato-Biliary Association
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about HPB
What CAS zone is HPB in?
In the 2025 upgraded edition of the CAS Journal Ranking, HPB is in Zone 3 of Medicine, and in Zone 3 of the minor category Gastroenterology & Hepatology / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of HPB?
The latest impact factor listed by LetPub is 2.94; CiteScore 5, h-index 118.
How long does peer review take at HPB?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 88 days (interquartile range 35–125 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of HPB?
According to the journal's author guidelines: Abstract: ≤ 200 words; Manuscript length: ≤ 5,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of HPB based?
Of the 78 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (28), United Kingdom (9) and Japan (8). Counted from the institutions listed on the board page; for reference only.
Which databases index HPB?
According to LetPub and DOAJ records, HPB is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is HPB open access, and what is the APC?
HPB is a hybrid journal. For open-access publication: APC about USD 4,100.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .